SNCA and Parkinson disease: It appears that perhaps the focus needs to be shifted from mechanisms underlying abnormal alpha-synuclein aggregation in the brain toward the disruption of the glucolipid metabolic pathways to provide a better understanding of the complex pathogenesis of PD.